Guides/Reports
AHA to Sanofi U.S./Sanofi Genzyme Re: Actions to Collect Data to Limit Distribution of Certain 340B Drugs
AHA to Sanofi U.S./Sanofi Genzyme Re: Actions to Collect Data to Limit Distribution of Certain 340B Drugs to Hospitals and Health Systems
AHA expresses profound concern about actions Sanofi U.S./Sanofi Genzyme are taking to collect data intended to limit the distribution of certain 340B drugs to hospitals and health systems.
Key Resources
Related Resources
Webinar Recordings